Gemina Laboratories Ltd. (CSE:GLAB)

Canada flag Canada · Delayed Price · Currency is CAD
0.3950
-0.0750 (-15.96%)
Oct 31, 2025, 9:05 AM EDT
-15.96%
Market Cap30.25M
Revenue (ttm)10.88K
Net Income (ttm)-4.01M
Shares Out76.57M
EPS (ttm)-0.05
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,865
Average Volume1,293
Open0.2750
Previous Close0.4700
Day's Range0.2750 - 0.4250
52-Week Range0.2750 - 1.2500
Beta0.22
RSI25.34
Earnings DateNov 28, 2025

About Gemina Laboratories

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Employees 6
Stock Exchange Canadian Securities Exchange
Ticker Symbol GLAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.